Category: New products

  • Bioactive Glass Reduces Decay in Tooth Cavity Fillings

    23 December 2015. An engineering group at Oregon State University adapted a type of glass material that in lab models slows the decay in teeth with composite cavity fillings. The team led by materials engineering professor Jamie Kruzic published its findings in the January 2016 issue of the journal Dental Materials. Kruzic, with colleagues from…

  • Start-Up Licenses Founder’s Research for Resistant Bacteria

    22 December 2015. A biotechnology company spun-off from University of California in San Diego is licensing technology from the university to develop treatments for bacterial infections now becoming resistant to conventional antibiotics. Financial terms of the licensing agreement between UC-San Diego and Forge Therapeutics were not disclosed. Forge Therapeutics, also in San Diego, is licensing…

  • Airway-on-Chip Model Simulates Asthma, COPD

    22 December 2015. A biomedical engineering lab at Harvard University developed a small chip device that acts as a model of human airways to study biological processes and test drugs for diseases such as COPD and asthma. A team from Harvard’s Wyss Institute for Biologically Inspired Engineering describe the device in yesterday’s issue of the…

  • Trial Shows Clot Prevention Drug Safe, Reversible

    18 December 2015. An early-stage clinical trial of an experimental drug to prevent blood clots during heart surgery shows the drug prevents platelet accumulation, while still safe and temporary to prevent excess bleeding. The study by a team at Tufts University Medical Center in Boston and Sinai Hospital of Baltimore appears in yesterday’s issue of…

  • Detailed Brain Activity Imaging Being Developed

    17 December 2015. An engineering group at University of Arizona is developing a new technology that promises to provide better images of electrical activity in the brain. The project, led by Arizona biomedical engineering professor Russell Witte, is funded by a three-year, $1.15 million grant from National Institute of Neurological Disorders and Stroke, part of…

  • Synthetic Peptide Protects Neurons Damaged by Parkinson’s

    16 December 2015. A study by a start-up biotechnology company and university medical center shows an engineered peptide can protect brain cells in lab mice from damage by toxins like those causing Parkinson’s disease. The findings by a team from Longevity Biotech in Philadelphia and University of Nebraska Medical Center in Omaha are published in…

  • Nanofibers, Stem Cells Studied for Rotator Cuff Repair

    16 December 2015. An engineering lab at Columbia University is researching a new regenerative process that better integrates human tendon and bone tissue to repair rotator cuff injuries. The team led by biomedical engineering professor Helen Lu is funded by $1.1 million grant from Congressionally Directed Medical Research Programs in the U.S. Department of Defense.…

  • Computer Vision Devised as Drug Discovery Technique

    15 December 2015. Pharmaceutical chemists at University of California in San Francisco developed techniques for adapting computer vision, like those used in robotics, to early-stage drug discovery. The team led by UC-San Francisco’s Steven Altschuler and Lani Wu describe its discovery in yesterday’s issue of the journal Nature Biotechnology (paid subscription required). Altschuler and Wu,…

  • Biotech to Explore Gut-Brain Connections, Raises $44M

    10 December 2015. A new biotechnology start-up plans to derive medical and consumer products from interactions between the human gut and brain. Kallyope Inc. in New York City is founded by biomedical researchers at Columbia University and raising $44 million its first venture funding round. Kallyope is designing a technology that harnesses communication pathways between…

  • Nanotech Multi-Drug Delivery Technique Devised for Cancer

    10 December 2015. A pharmacy lab at Oregon State University developed a technique for combining three drugs into nanoscale particles that treat melanoma spreading to lymph nodes in lab animals. The team led by Oregon State pharmacy professor Adam Alani published its proof-of-concept findings last month in Journal of Controlled Release (paid subscription required). Alani’s…